APA (7th ed.) Citation

M, N., S, T., Y, M., K, N., M, I., N, T., & K, U. (2025). Novel tetravalent bispecific antibody, PSMA/TRAIL‑R2 REGULGENT™, induces selective tumor cell apoptosis without hepatotoxicity. Oncology reports, 54(5), . https://doi.org/10.3892/or.2025.8988

Chicago Style (17th ed.) Citation

M, Nakayama, Takagi-Maeda S, Machino Y, Nihira K, Inoue M, Takahashi N, and Usami K. "Novel Tetravalent Bispecific Antibody, PSMA/TRAIL‑R2 REGULGENT™, Induces Selective Tumor Cell Apoptosis Without Hepatotoxicity." Oncology Reports 54, no. 5 (2025). https://doi.org/10.3892/or.2025.8988.

MLA (9th ed.) Citation

M, Nakayama, et al. "Novel Tetravalent Bispecific Antibody, PSMA/TRAIL‑R2 REGULGENT™, Induces Selective Tumor Cell Apoptosis Without Hepatotoxicity." Oncology Reports, vol. 54, no. 5, 2025, https://doi.org/10.3892/or.2025.8988.